2001 to 2005
Stevens Y, Lawrence B, Correia R, Burch L, Thomas P, Clifford J, Detzer MJ, Kneeland T, Quinton HB, O’Connor GT. Self-reported income from CF patients and families: differences in income distribution by age and gender. NNECFC. 2004.
Stokes DC, Zuckerman JB, Lahiri T, Feenan L, Parker HW. Increasing macrolide resistance in staphylococcal isolates from Cystic Fibrosis patients treated with azithromycin: does it matter? NNECFC. NACFC. 2004.
AM Cairns, HB Quinton, EJ Caldwell, R Harder, JC Leiter, HW Parker, G Wager, JB Zuckerman, TA Stukel, GT O’Connor. Variability in Rates of FEV1 Decline Across Cystic Fibrosis Centers in the United States. NNECFC. 2004.
AM Cairns, E Caldwell, H Quinton, J Dziodzio, J Zuckerman, HW Parker, J Leiter, R Harder, T Kneeland, G Wager. Variation in Practice Patterns at CF Clinical Care Centers in Northern New England. NNECFC. 2004.
H LeClerc, J Maddock, C Geer, M Buteyn, M Jones, E Dionne, PB Murray, E Caldwell, HB Quinton, GT O’Connor. Regional and national variation in rates of pediatric CF patients at risk of and in nutritional failure: Opportunities for improvement. NNECFC. 2002.
T Lahiri, AM Cairns, J Zuckerman, WH Parker, L Feenan, J Swartz, T Lambert, T Lever, R Harder, M Bilodeau, T Kneeland, HB Quinton, GT O’Connor. Understanding Clinician Prescribing Patterns for Aerosolized Tobramycin and DNase. NNECFC. 2002.
GT O’Connor, H Quinton, R Kahn, P Robichaud, J Maddock, T Lever, J Brooks. Case-Mix Adjustment in Cystic Fibrosis: A Model for Predicting Survival Based on Patient and Disease Characteristics Present at Diagnosis. NNECFC. 2002.
Robichaud, MJ Detzer, T Kneeland, HB Quinton, LM Feenan, WE Boyle, WP Parker, GT O’Connor. A Feedback Report to Track CF Adult Health-Related Quality of Life (HRQOL) and Key Physiologic Measures. NNECFC. 2001.